Drug intelligence / Profile preview

indigo naturalis

Development stage
Phase 3
Lead developer
China Medical University Hospital
Administration
Oral, Topical
01

Overview

**Indigo naturalis** is a traditional Chinese herbal drug and plant-derived topical/oral medicinal substance prepared from indigo-containing plants such as *Baphicacanthus cusia* and used clinically most prominently for inflammatory skin diseases and ulcerative colitis. In the provided sources, it has been studied as a **topical ointment/oil extract** for plaque psoriasis, nail psoriasis, and atopic dermatitis, and as an **oral herbal medicine** for ulcerative colitis. Its pharmacology appears to be multi-component and polypharmacologic rather than driven by a single defined target: major constituents include **indirubin**, **tryptanthrin**, and **indigo**; published mechanistic work links topical activity in psoriasis to **downregulation of the IL-17 pathway**, with tryptanthrin showing anti-IL-17-associated effects in keratinocyte assays, while oral activity in ulcerative colitis has been linked to **aryl hydrocarbon receptor activation** by indigo/indirubin. Clinical studies in the provided material report efficacy signals in psoriasis, nail psoriasis, atopic dermatitis, and treatment-refractory ulcerative colitis, generally with topical formulations appearing locally tolerable, though oral indigo naturalis has broader safety concerns in the literature and should not be conflated with the topical preparations.

Brand names
Lindioil
Other names
Qing Dai青黛青黛膏
02

Targets

JAK3 (Janus kinase 3)IFNGR1 (Interferon gamma receptor)TLR4 (Toll-like receptor 4)AHR (Aryl hydrocarbon receptor)

Beyond the preview

Go deeper on indigo naturalis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on indigo naturalis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call